Journal Club: GLP-1 Medications for Weight Loss in the Real World

New research on GLP-1 weight loss medications is coming out quickly. We’re learning about real-world outcomes with large patient cohorts. Unsurprisingly, Wegovy (semaglutide/Ozempic) and Zepbound (Tirzepatide/Mounjaro) are performing differently in real world settings. A recent large study of over 8,000 patients using clinical data found these medications to be less effective, with much higher rates of discontinuation, and being used much differently than in the phase 3 trials. Join us to unpack this study at our August members-only journal club.

Article for discussion: Gasoyan H, Butsch WS, Schulte R, et al. Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status. Obesity (Silver Spring). Published online June 10, 2025. doi:10.1002/oby.24331

We recommend watching at least part one of the three-part GLP-1 education series, which is available to all ASDAH members at no additional cost! Not yet a member? Join today and get access to this and over 20 other courses.

The CPE activity is pending CDR review and approval for 1 CPEU.

IMPORTANT DETAILS

About this Event

• This event is an ASDAH Member exclusive and only available to current ASDAH Members.
• This event is being offered for 1 CE

Certificates for continuing education purposes are only available to Professional Members and for ticket levels other than the Community, Student, Retiree ticket. The CPE activity application for this event is pending CDR review and approval for 1 CPEU. Certificates of Attendance available to support individual submission for CEUs for other professions.

Joining via Zoom

After registering for this Virtual Event, you will be emailed a link that will allow you to join the live event 24 hours before the event.

This event will require you to use Zoom. Please download any needed applications and check system requirements prior to the event.

Recorded Event

This event will not be recorded.

Automatic captioning including translation into over 20 languages including Spanish and French will be available via Zoom.